Monday, October 16, 2017

Banner Image - Patient Safety, Product Integrity, Fair Pricing

Study Shows a Positive Mood Could Boost Effectiveness of Flu Vaccine

female expressing sad and happy emotions on photographs

In this Issue


•	IVIG/Albumin Supply Index
•	Open Market Pricing
•	New Products from FFF
•	Current Medicare IVIG / SCIG Rates
•	Resources
•	Subscribe to IG Living and BioSupply Trends Quarterly

Researchers at the University of Nottingham in England have found evidence that being in a positive mood when receiving an influenza vaccine can increase its protective effect. The study is the first to examine several psychological and behavioral factors that have been shown to affect how well vaccinations work. [ read more ]

New Technology Could Deliver All Childhood Vaccinations in a Single Injection

Massachusetts Institute of Technology researchers have invented new technology that could enable every childhood vaccination to be given in a single injection using microscopic capsules injected into the body that release the dose and required boosters at exactly the appropriate time. [ read more ]

Universal Flu Vaccine Begins Two-Year Clinical Trial

Researchers at the University of Oxford have begun a two-year clinical trial to test a universal influenza vaccine in more than 2,000 patients. The vaccine works by using proteins found in the core of the virus that remain stable, rather than those on its surface that mutate all the time. [ read more ]

Industry News

From CSL Behring

The U.S. Food and Drug Administration has approved Privigen (immune globulin intravenous [human] 10% liquid) to treat adults with chronic inflammatory demyelinating polyneuropathy to improve neuromuscular disability. [ read more ]

From Amgen

Mvasi (bevacizumab-awwb) is the first U.S. Food and Drug Administration-approved biosimilar cancer drug. It was approved as a biosimilar to Avastin (bevacizumab) for the treatment of adults with certain color, lung, brain, kidney and cervical cancers. [ read more ]

From Novartis

Novartis' Kymriah (tisagenlecleucel) has been approved by the U.S. Food and Drug Administration to treat pediatric acute lymphoblastic leukemia. [ read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Supply Index from July 2017 - October 2017

Log in to BioSupply for IVIG and Albumin Product Pricing

What's New at FFF

• PANTOPRAZOLE SODIUM (AUROMEDICS PHARMA LLC)

PANTOPRAZOLE SODIUM (injection) is a proton pump inhibitor indicated for 1) short-term treatment (seven to 10 days) of gastroesophageal reflux disease associated with a history of erosive esophagitis and 2) pathological hypersecretion conditions, including Zollinger-Ellison syndrome. It is supplied in 40 mg pantoprazole freeze-dried powder in a single-dose vial for reconstitution.

For more information about PANTOPRAZOLE SODIUM,
login to biosupply.fffenterprises.com

These products are available thru FFF Enterprises' BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective Oct. 1, 2017, through Dec. 31, 2017.

Product	J Codes	ASP + 6% (before sequester)	ASP + 4.3%* (after sequester)
IVIG
Carimune NF	J1566	$68.56	$67.46
Flebogamma	J1572	$59.67	$58.71
Gammagard S/D	J1566	$68.56	$67.46
Gammaplex	J1557	$82.16	$80.84
Octagam	J1568	$73.24	$72.06
Privigen	J1459	$77.01	$75.78
SCIG
CUVITRU **	J3490/J3590/J7799	-	-
Hizentra	J1559	$98.13	$96.56
HyQvia	J1575	$131.36	$129.25
IVIG / SCIG
Gammagard Liquid	J1569	$79.57	$78.29
Gammaked	J1561	$77.89	$76.64
Gamunex-C	J1561	$77.89	$76.64

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

Log in to BioSupply for Immune Globulin Products

Resources

FFF customers may order the following complementary resources to help you with your practice:


•	IG Immune Globulin (Human)
•	Hyperimmune Globulins
•	Anti-Inhibitor, Factor VIIa & IX
•	Factor VIII & von Willebrand Factor
•	Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.